학술논문
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
Document Type
Article
Source
In: Health Technology Assessment . (Health Technology Assessment, January 2024, 28(4))
Subject
Language
English
ISSN
20464924
13665278
13665278